P. K. M�ller

404 total citations
9 papers, 314 citations indexed

About

P. K. M�ller is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, P. K. M�ller has authored 9 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Rheumatology and 3 papers in Genetics. Recurrent topics in P. K. M�ller's work include Connective tissue disorders research (3 papers), Dermatological and Skeletal Disorders (1 paper) and RNA modifications and cancer (1 paper). P. K. M�ller is often cited by papers focused on Connective tissue disorders research (3 papers), Dermatological and Skeletal Disorders (1 paper) and RNA modifications and cancer (1 paper). P. K. M�ller collaborates with scholars based in Germany. P. K. M�ller's co-authors include Steffen Gay, Thomas Krieg, K. Matzen, Jürgen Brinckmann, Helmut H. Wolff, Hartwig Lehmann, Wolfgang L. Gross, Chunlin Yang, Jörn Kekow and Thomas Krieg and has published in prestigious journals such as Cellular and Molecular Life Sciences, Cell and Tissue Research and Human Genetics.

In The Last Decade

P. K. M�ller

9 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. K. M�ller Germany 8 137 106 91 59 29 9 314
Bertram F. Pontz Germany 9 93 0.7× 52 0.5× 71 0.8× 23 0.4× 79 2.7× 13 338
Lara Cresswell United Kingdom 8 83 0.6× 63 0.6× 134 1.5× 29 0.5× 8 0.3× 9 317
Manuela Pigors Germany 11 108 0.8× 54 0.5× 66 0.7× 62 1.1× 124 4.3× 17 305
Deborah Ferrari United States 10 325 2.4× 121 1.1× 82 0.9× 26 0.4× 63 2.2× 12 423
R. Evangelisti Italy 14 276 2.0× 42 0.4× 155 1.7× 18 0.3× 86 3.0× 35 473
Xuming Zhu China 11 279 2.0× 78 0.7× 76 0.8× 24 0.4× 37 1.3× 19 409
Jennifer Boyle United States 11 245 1.8× 68 0.6× 65 0.7× 17 0.3× 39 1.3× 16 404
J. L. Holton United Kingdom 5 218 1.6× 78 0.7× 15 0.2× 48 0.8× 152 5.2× 6 366
Zhuxiang Nie United Kingdom 9 262 1.9× 98 0.9× 33 0.4× 105 1.8× 175 6.0× 12 533
Gabriele Gillessen-Kaesbach Germany 5 349 2.5× 25 0.2× 265 2.9× 42 0.7× 42 1.4× 5 506

Countries citing papers authored by P. K. M�ller

Since Specialization
Citations

This map shows the geographic impact of P. K. M�ller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. K. M�ller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. K. M�ller more than expected).

Fields of papers citing papers by P. K. M�ller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. K. M�ller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. K. M�ller. The network helps show where P. K. M�ller may publish in the future.

Co-authorship network of co-authors of P. K. M�ller

This figure shows the co-authorship network connecting the top 25 collaborators of P. K. M�ller. A scholar is included among the top collaborators of P. K. M�ller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. K. M�ller. P. K. M�ller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kruse, Charli, et al.. (2003). The multi-KH protein vigilin associates with free and membrane-bound ribosomes. Cellular and Molecular Life Sciences. 60(10). 2219–2227. 20 indexed citations
2.
Rohwedel, J., et al.. (2003). Evidence for posttranscriptional regulation of the multi K homology domain protein vigilin by a small peptide encoded in the 5? leader sequence. Cellular and Molecular Life Sciences. 60(8). 1705–1715. 6 indexed citations
3.
Lehmann, Hartwig, et al.. (1994). Ehlers-Danlos syndrome type VII: phenotype and genotype. Archives of Dermatological Research. 286(8). 425–428. 10 indexed citations
4.
Brinckmann, Jürgen, et al.. (1994). Analysis of the age-related composition of human skin collagen and collagens synthesized by fibroblast culture. Archives of Dermatological Research. 286(7). 391–395. 24 indexed citations
5.
M�ller, P. K., et al.. (1993). Expression of vigilin in chicken cartilage and bone. Cell and Tissue Research. 273(2). 381–389. 30 indexed citations
6.
Yang, Chunlin, Jürgen Brinckmann, Hartwig Lehmann, et al.. (1993). Autoantibodies to cartilage collagens in relapsing polychondritis. Archives of Dermatological Research. 285(5). 245–249. 74 indexed citations
7.
Krieg, Thomas, et al.. (1979). Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant. Human Genetics. 46(1). 41–49. 30 indexed citations
8.
M�ller, P. K., et al.. (1977). Presence of type III collagen in bone from a patient with osteogenesis imperfecta. European Journal of Pediatrics. 125(1). 29–37. 50 indexed citations
9.
Krieg, Thomas, et al.. (1977). Progeria: A cell culture study and clinical report of familial incidence. European Journal of Pediatrics. 124(2). 101–111. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026